NAL 0.00% 0.6¢ norwood abbey limited

+ +where is nal heading?+ +, page-2

  1. 22,691 Posts.
    From NAL, date: 6 Jan. 2003.

    "The Clinical studies relating to Bone Marrow Transplantation (now more often involving the less invasive blood haemopoietic stem cell transplantation) have progressed extremely well.

    Although the preliminary data from those studies has not, for commercial reasons, been published at this time, there has been considerable interest created amongst the specialist clinical fraternity.

    Norwood scientists have been approached by 5 of the most significant hospitals/clinical groups in the World. Four of these centres are based in the USA".
    _______________________

    Comment:
    "Preliminary data cannot for commercial reasons be published just now".

    Gerry
 
watchlist Created with Sketch. Add NAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.